EcoDrugPlus

Complement C1s

Ensembl ID : ENSMLUG00000028357
Gene Symbol: C1S
2 Cross references
199 Possible Orthologues:

Complement C5

Ensembl ID : ENSMLUG00000009610
Gene Symbol: C5
2 Cross references
208 Possible Orthologues:

Complement Factor D

Ensembl ID : ENSMLUG00000003311
Gene Symbol: CFD
2 Cross references
133 Possible Orthologues:

Corticotropin Releasing Hormone Receptor 1

Ensembl ID : ENSMLUG00000011249
Gene Symbol: CRHR1
4 Cross references
240 Possible Orthologues:

Cyclin D1

Ensembl ID : ENSMLUG00000011181
Gene Symbol: CCND1
2 Cross references
277 Possible Orthologues:

Cyclin Dependent Kinase 2

Ensembl ID : ENSMLUG00000004713
Gene Symbol: CDK2
2 Cross references
202 Possible Orthologues:

Cyclin Dependent Kinase 5

Ensembl ID : ENSMLUG00000014708
Gene Symbol: CDK5
2 Cross references
169 Possible Orthologues:

Cyclin Dependent Kinase 6

Ensembl ID : ENSMLUG00000011872
Gene Symbol: CDK6
2 Cross references
198 Possible Orthologues:

Cyclin Dependent Kinase 7

Ensembl ID : ENSMLUG00000002960
Gene Symbol: CDK7
2 Cross references
213 Possible Orthologues:

Cytidine Deaminase

Ensembl ID : ENSMLUG00000010295
Gene Symbol: CDA
2 Cross references
224 Possible Orthologues:

Cytochrome P450 Family 17 Subfamily A Member 1

Ensembl ID : ENSMLUG00000004363
Gene Symbol: CYP17A1
2 Cross references
210 Possible Orthologues:

Cytochrome P450 Family 19 Subfamily A Member 1

Ensembl ID : ENSMLUG00000009854
Gene Symbol: CYP19A1
4 Cross references
315 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).